130 related articles for article (PubMed ID: 26332341)
41. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
42. Demethoxycurcumin alters gene expression associated with DNA damage, cell cycle and apoptosis in human lung cancer NCI-H460 cells in vitro.
Ko YC; Hsu SC; Liu HC; Hsiao YT; Hsia TC; Yang ST; Hsu WH; Chung JG
In Vivo; 2015; 29(1):83-94. PubMed ID: 25600535
[TBL] [Abstract][Full Text] [Related]
43. Bisdemethoxycurcumin Induces apoptosis in activated hepatic stellate cells via cannabinoid receptor 2.
Lee PJ; Woo SJ; Jee JG; Sung SH; Kim HP
Molecules; 2015 Jan; 20(1):1277-92. PubMed ID: 25594342
[TBL] [Abstract][Full Text] [Related]
44. Active Compounds from
Lesmana R; Susianti ; Pediatama T; Sylviana N; Susanti Pratiwi Y; Goenawan H; Supratman U
Pak J Biol Sci; 2021 Jan; 24(1):35-41. PubMed ID: 33683029
[TBL] [Abstract][Full Text] [Related]
45. Allyl isothiocyanate induces DNA damage and inhibits DNA repair-associated proteins in a human gastric cancer cells in vitro.
Shih YL; Hsu SY; Lai KC; Chueh FS; Huang YL; Kuo CL; Chen YL; Chen CJ; Peng SF; Huang WW; Lu HF
Environ Toxicol; 2024 Mar; 39(3):1303-1314. PubMed ID: 37966020
[TBL] [Abstract][Full Text] [Related]
46. Microfluidic fabricated bisdemethoxycurcumin thermosensitive liposome with enhanced antitumor effect.
Cao X; Liu Q; Shi W; Liu K; Deng T; Weng X; Pan S; Yu Q; Deng W; Yu J; Wang Q; Xiao G; Xu X
Int J Pharm; 2023 Jun; 641():123039. PubMed ID: 37225026
[TBL] [Abstract][Full Text] [Related]
47. Gallic acid provokes DNA damage and suppresses DNA repair gene expression in human prostate cancer PC-3 cells.
Liu KC; Ho HC; Huang AC; Ji BC; Lin HY; Chueh FS; Yang JS; Lu CC; Chiang JH; Meng M; Chung JG
Environ Toxicol; 2013 Oct; 28(10):579-87. PubMed ID: 21887735
[TBL] [Abstract][Full Text] [Related]
48. Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R).
Andjelkovic T; Pesic M; Bankovic J; Tanic N; Markovic ID; Ruzdijic S
Cancer Biol Ther; 2008 Jul; 7(7):1024-32. PubMed ID: 18414057
[TBL] [Abstract][Full Text] [Related]
49. Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung cancer cell lines.
Liu YL; Yang HP; Gong L; Tang CL; Wang HJ
Mol Med Rep; 2011; 4(4):675-9. PubMed ID: 21484077
[TBL] [Abstract][Full Text] [Related]
50. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
[TBL] [Abstract][Full Text] [Related]
51. The inhibitory effect of turmeric curcuminoids on matrix metalloproteinase-3 secretion in human invasive breast carcinoma cells.
Boonrao M; Yodkeeree S; Ampasavate C; Anuchapreeda S; Limtrakul P
Arch Pharm Res; 2010 Jul; 33(7):989-98. PubMed ID: 20661707
[TBL] [Abstract][Full Text] [Related]
52. Curcumin derivatives: molecular basis of their anti-cancer activity.
Basile V; Ferrari E; Lazzari S; Belluti S; Pignedoli F; Imbriano C
Biochem Pharmacol; 2009 Nov; 78(10):1305-15. PubMed ID: 19580791
[TBL] [Abstract][Full Text] [Related]
53. Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitro.
Chiang IT; Wang WS; Liu HC; Yang ST; Tang NY; Chung JG
Oncol Rep; 2015 Oct; 34(4):1853-74. PubMed ID: 26238775
[TBL] [Abstract][Full Text] [Related]
54. Synthetic curcumin analog: inhibiting the invasion, angiogenesis, and metastasis in human laryngeal carcinoma cells via NF-kB pathway.
Mohankumar K; Francis AP; Pajaniradje S; Rajagopalan R
Mol Biol Rep; 2021 Aug; 48(8):6065-6074. PubMed ID: 34355287
[TBL] [Abstract][Full Text] [Related]
55. Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damage.
Ha K; Fiskus W; Rao R; Balusu R; Venkannagari S; Nalabothula NR; Bhalla KN
Mol Cancer Ther; 2011 Jul; 10(7):1194-206. PubMed ID: 21566061
[TBL] [Abstract][Full Text] [Related]
56. Protective Effects of Minor Components of Curcuminoids on Hydrogen Peroxide-Treated Human HaCaT Keratinocytes.
Liu YH; Lin YS; Huang YW; Fang SU; Lin SY; Hou WC
J Agric Food Chem; 2016 May; 64(18):3598-608. PubMed ID: 27094403
[TBL] [Abstract][Full Text] [Related]
57. Promising anti-tumor properties of bisdemethoxycurcumin: A naturally occurring curcumin analogue.
Ramezani M; Hatamipour M; Sahebkar A
J Cell Physiol; 2018 Feb; 233(2):880-887. PubMed ID: 28075008
[TBL] [Abstract][Full Text] [Related]
58. New orally active DNA minor groove binding small molecule CT-1 acts against breast cancer by targeting tumor DNA damage leading to p53-dependent apoptosis.
Saini KS; Hamidullah ; Ashraf R; Mandalapu D; Das S; Siddiqui MQ; Dwivedi S; Sarkar J; Sharma VL; Konwar R
Mol Carcinog; 2017 Apr; 56(4):1266-1280. PubMed ID: 27813185
[TBL] [Abstract][Full Text] [Related]
59. Up-regulation of heme oxygenase-1 expression through CaMKII-ERK1/2-Nrf2 signaling mediates the anti-inflammatory effect of bisdemethoxycurcumin in LPS-stimulated macrophages.
Kim AN; Jeon WK; Lee JJ; Kim BC
Free Radic Biol Med; 2010 Aug; 49(3):323-31. PubMed ID: 20430097
[TBL] [Abstract][Full Text] [Related]
60. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
